TRIF promotes angiotensin II-induced cross-talk between fibroblasts and macrophages in atrial fibrosis

Biochemical and Biophysical Research Communications

Volumn 464, Issue 1, 2015, Pages 100-105

  Chen, Xiao Qing ^a   Zhang, Dao Liang ^a   Zhang, Ming Jian ^b   Guo, Meng ^b   Zhan, Yang Yang ^b   Liu, Fang ^b   Jiang, Wei Feng ^a   Zhou, Li ^a   Zhao, Liang ^a   Wang, Quan Xing ^b   Liu, Xu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibroblasts; Atrial fibrosis; Macrophages; TRIF

Indexed keywords

ANGIOTENSIN II; CHLORDANE; LOSARTAN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TICAM1 PROTEIN, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

AORTA VALVE REPLACEMENT; ARTICLE; ATRIAL FIBRILLATION; CELL INFILTRATION; CELL PROLIFERATION; CHEMOTAXIS; CYTOKINE RELEASE; HEART ATRIUM; HEART FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MITRAL VALVE REPLACEMENT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL COMMUNICATION; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANGIOTENSIN II; ANIMALS; ATRIAL FIBRILLATION; CELL COMMUNICATION; CELL PROLIFERATION; CHEMOTAXIS; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HEART ATRIA; HUMANS; LOSARTAN; MACROPHAGES; MICE; MICE, INBRED C57BL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84937635227     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.05.131     Document Type: Article

References (29)

1. Y.K. Iwasaki, K. Nishida, T. Kato, and S. Nattel Atrial fibrillation pathophysiology: implications for management Circulation 124 2011 2264 2274
2. S. Nattel, and M. Harada Atrial remodeling and atrial fibrillation: recent advances and translational perspectives J. Am. Coll. Cardiol. 63 22 2014 2335 2345
3. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J. Am. Coll. Cardiol. 50 2007 2021 2028
4. T. Yamashita, A. Sekiguchi, Y.K. Iwasaki, T. Date, K. Sagara, H. Tanabe, H. Suma, H. Sawada, and T. Aizawa Recruitment of immune cells across atrial endocardium in human atrial fibrillation Circ. J. 74 2 2010 262 270
5. X.Q. Chen, X. Liu, Q.X. Wang, M.J. Zhang, M. Guo, F. Liu, W.F. Jiang, and L. Zhou Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway Exp. Cell. Res. 330 1 2015 43 55
6. M. Landström The TAK1-TRAF6 signalling pathway Int. J. Biochem. Cell. Biol. 42 2010 585 589
7. S. Sato, M. Sugiyama, M. Yamamoto, Y. Watanabe, T. Kawai, K. Takeda, and S. Akira Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling J. Immunol. 171 2003 4304 4310
8. O. Adam, K. Theobald, D. Lavall, M. Grube, H.K. Kroemer, S. Ameling, H.J. Schäfers, M. Böhm, and U. Laufs Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation J. Mol. Cell. Cardiol. 50 2011 678 685
9. D.G. Alleva, E.B. Johnson, F.M. Lio, S.A. Boehme, P.J. Conlon, and P.D. Crowe Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma J. Leukoc. Biol. 71 2002 677 685
10. J. Gu, X. Liu, Q.X. Wang, H.W. Tan, M. Guo, W.F. Jiang, and L. Zhou Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts Exp. Cell. Res. 318 2012 2105 2115
11. J. Gu, X. Liu, Q.X. Wang, M. Guo, F. Liu, Z.P. Song, and D.D. Zhang Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models J. Mol. Cell. Cardiol. 65 2013 1 8
12. R. Shen, E.R. Drelichman, D. Bimczok, C. Ochsenbauer, J.C. Kappes, J.A. Cannon, D. Tudor, M. Bomsel, L.E. Smythies, and P.D. Smith GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonicepithelium J. Immunol. 184 2010 3648 3655
13. R.J. Aviles, D.O. Martin, C. Apperson-Hansen, P.L. Houghtaling, P. Rautaharju, R.A. Kronmal, R.P. Tracy, D.R. Van Wagoner, B.M. Psaty, M.S. Lauer, and M.K. Chung Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
14. N. Sata, N. Hamada, T. Horinouchi, S. Amitani, T. Yamashita, Y. Moriyama, and K. Miyahara C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn. Heart. J. 45 2004 441 445
15. D.S. Conway, P. Buggins, E. Hughes, and G.Y. Lip Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation Am. Heart. J. 148 2004 462 466
16. P. Doyon, and M.J. Servant Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells J. Biol. Chem. 285 2010 30708 30718
17. S.J. Watkins, G.M. Borthwick, R. Oakenfull, A. Robson, and H.M. Arthur Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent Hypertens. Res. 35 2012 393 398
18. Y. Ma, X. Zhang, H. Bao, S. Mi, W. Cai, H. Yan, Q. Wang, Z. Wang, J. Yan, G.C. Fan, M.L. Lindsey, and Z. Hu Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice PLoS One 7 2012 e40763
19. L.K. Curtiss, A.S. Black, D.J. Bonnet, and P.S. Tobias Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists J. Lipid. Res. 53 2012 2126 2132
20. A.M. Lundberg, D.F. Ketelhuth, M.E. Johansson, N. Gerdes, S. Liu, M. Yamamoto, S. Akira, and G.K. Hansson Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis Cardiovasc. Res. 99 2013 364 373
21. N. Hinglais, D. Heudes, A. Nicoletti, C. Mandet, M. Laurent, and J.B. Bariéty J,Michel Colocalization of myocardial fibrosis and inflammatory cells in rats Lab. Invest. 70 1994 286 294
22. A. Nicoletti, D. Heudes, C. Mandet, N. Hinglais, J. Bariety, and J.B. Michel Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats Cardiovasc. Res. 32 1996 1096 1107
23. F. Kuwahara, H. Kai, K. Tokuda, M. Takeya, A. Takeshita, K. Egashira, and T. Imaizumi Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43 2004 739 745
24. T.A. Wynn, and T.R. Ramalingam Mechanisms of fibrosis: therapeutic translation for fibrotic disease Nat. Med. 18 2012 1028 1040
25. A. Desmoulière, A. Geinoz, F. Gabbiani, and G. Gabbiani Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts J. Cell. Biol. 122 1993 103 111
26. B.B. Moore, L. Murray, A. Das, C.A. Wilke, A.B. Herrygers, and G.B. Toews The role of CCL12 in the recruitment of fibrocytes and lung fibrosis Am. J. Respir. Cell. Mol. Biol. 35 2006 175 181
27. P.E. Kolattukudy, T. Quach, S. Bergese, S. Breckenridge, J. Hensley, R. Altschuld, G. Gordillo, S. Klenotic, C. Orosz, and J. Parker-Thornburg Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle Am. J. Pathol. 152 1998 101 111
28. Q. Capers 4th, R.W. Alexander, P. Lou, H. De Leon, J.N. Wilcox, N. Ishizaka, A.B. Howard, and W.R. Taylor Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats Hypertension 30 1997 1397 1402
29. L. Gu, S.C. Tseng, and B.J. Rollins Monocyte chemoattractant protein-1 Chem. Immunol. 72 1999 7 29